N'CRYPT is a proprietary portfolio of anti-counterfeit pharmaceutical security solutions from Amcor, which represent an innovative and proven approach in delivering patient safety, supply chain integrity and pharmaceutical and medical brand protection, it claims.
This solution combines multiple layers of technologies, such as specialized printing techniques and authentication features, with secure production and supply chain processes to protect brands from counterfeiting.
The N'CRYPT portfolio includes: fine line print: security printing, including patented technologies, plus brand-enhancing overt or cost effective covert options, including microtext, guilloche or UV moiré.
Overt technologies includes colour shift inks, multiple holographic options, foil embossing and special inks. Covert technologies comprise flexible taggant applications in inks and lacquers to unique digital watermarking. The company also offer its new EZ-ID solution which fulfills both supply chain and authentication requirements, providing overall integrity to the system, it says
